About microRNAsTherapeutic OpportunitiesDrugs & Technologies

News & Events

Archived Press Releases

2004  |  2005  |  2007  |  2008  |  2009  |  2010

10.31.05 New RNAi Approach for In Vivo Therapeutic Silencing of MicroRNAs is Demonstrated by Alnylam and Rockefeller University Scientists

09.13.05 Alnylam and Isis License Intellectual Property for MicroRNA Gene Involved in Hepatitis C Viral Infection

Media Contacts

Regulus Therapeutics
Zachary Zimmerman, Ph.D.,
858-202-6300

Media
Russo Partners
Heidi Chokeir, Ph.D.,
619-528-2217


Subscribe

Enter your email address to stay up to date with the latest Regulus news.